Use of extracorporeal life support in adults with severe acute respiratory failure

Expert Review of Respiratory Medicine

Volumn 5, Issue 5, 2011, Pages 627-633

  Rehder, Kyle J ^a   Turner, David A ^a   Cheifetz, Ira M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acute lung injury; adult; etiology; extracorporeal membrane oxygenation; H1N1 subtype; influenza A virus; mechanical ventilation; mortality; respiratory distress syndrome; respiratory insufficiency; therapy

Indexed keywords

2009 H1N1 INFLUENZA; ACUTE RESPIRATORY FAILURE; ADULT; ALLOPATHY; ARTIFICIAL VENTILATION; CONGENITAL DIAPHRAGM HERNIA; EXTRACORPOREAL OXYGENATION; HUMAN; INTENSIVE CARE UNIT; MECONIUM ASPIRATION; MORTALITY; PERSISTENT PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; RESPIRATORY DISTRESS SYNDROME; RESUSCITATION; REVIEW; SEPSIS; SURVIVAL RATE; VENTILATOR INDUCED LUNG INJURY; VIRUS PNEUMONIA;

EID: 80053352837     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.57     Document Type: Review

References (75)

1. Briel M, Meade M, Mercat A et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303(9), 865-873 (2010).
2. Esan A, Hess DR, Raoof S, George L, Sessler CN. Severe hypoxemic respiratory failure: part 1 - ventilatory strategies. Chest 137(5), 1203-1216 (2010).
3. Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med. 342(18), 1334-1349 (2000). (Pubitemid 30408719)
4. Bartlett RH. Extracorporeal life support in the management of severe respiratory failure. Clin. Chest Med. 21(3), 555-561 (2000).
5. Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit. Care 4(3), 156-168 (2000). (Pubitemid 30368048)
6. Zapol WM, Snider MT, Hill JD et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242(20), 2193-2196 (1979). (Pubitemid 10195729)
7. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am. J. Respir. Crit. Care Med. 157(1), 294-323 (1998). (Pubitemid 28071297)
8. Peltekova V, Engelberts D, Otulakowski G, Uematsu S, Post M, Kavanagh BP. Hypercapnic acidosis in ventilator-induced lung injury. Intensive Care Med. 36(5), 869-878 (2010).
9. Plataki M, Hubmayr RD. The physical basis of ventilator-induced lung injury. Expert Rev. Respir. Med. 4(3), 373-385 (2010).
10. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Curr. Opin. Crit. Care 8(1), 12-20 (2002). (Pubitemid 34165523)
11. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342(18), 1301-1308 (2000).
12. Gajic O, Dara SI, Mendez JL et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit. Care Med. 32(9), 1817-1824 (2004). (Pubitemid 39202355)
13. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans. Am. Soc. Artif. Intern. Organs 22, 80-93 (1976).
14. Hill JD, OBrien TG, Murray JJ et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N. Engl. J. Med. 286(12), 629-634 (1972).
15. The Extracorporal Life Support Organization. ECLS Registry Report. Ann Arbor, MI, USA (2011
16. Bahrami KR, Van Meurs KP. ECMO for neonatal respiratory failure. Semin. Perinatol. 29(1), 15-23 (2005).
17. Hansell DR. Extracorporeal membrane oxygenation for perinatal and pediatric patients. Respir. Care 48(4), 352-362; discussion 363-356 (2003).
18. Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst. Rev. (3), CD001340 (2008).
19. Green TP, Moler FW, Goodman DM. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Extracorporeal Life Support Organization. Crit. Care Med. 23(6), 1132-1139 (1995).
20. Mehta NM, Turner D, Walsh B et al. Factors associated with survival in pediatric extracorporeal membrane oxygenation - a single-center experience. J. Pediatr. Surg. 45(10), 1995-2003 (2010).
21. Pettignano R, Fortenberry JD, Heard ML et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr. Crit. Care Med. 4(3), 291-298 (2003).
22. Gattinoni L, Pesenti A, Mascheroni D et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256(7), 881-886 (1986). (Pubitemid 16077399)
23. Morris AH, Wallace CJ, Menlove RL et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 295-305 (1994). (Pubitemid 24068971)
24. Davies A, Jones D, Bailey M et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 302(17), 1888-1895 (2009).
25. Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit. Care Med. 38(6), 1398-1404 (2010).
26. Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO. Perfusion 19(1), 17-23 (2004). (Pubitemid 38386645)
27. Bermudez CA, Rocha RV, Sappington PL, Toyoda Y, Murray HN, Boujoukos AJ. Initial experience with single cannulation for venovenous extracorporeal oxygenation in adults. Ann. Thorac. Surg. 90(3), 991-995 (2010).
28. Kolla S, Awad SS, Rich PB, Schreiner RJ, Hirschl RB, Bartlett RH. Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann. Surg. 226(4), 544-564; discussion 565-546 (1997).
29. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med. 35(12), 2105-2114 (2009
30. Frank AJ, Thompson BT. Pharmacological treatments for acute respiratory distress syndrome. Curr. Opin. Crit. Care 16(1), 62-68 (2010).
31. Lewis JF, Veldhuizen RA. The future of surfactant therapy during ALI/ARDS. Semin Respir Crit. Care Med. 27(4), 377-388 (2006). (Pubitemid 44272606)
32. Maruscak A, Lewis JF. Exogenous surfactant therapy for ARDS. Expert Opin. Investig. Drugs 15(1), 47-58 (2006). (Pubitemid 43034150)
33. Meduri GU, Marik PE, Chrousos GP et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med. 34(1), 61-69 (2008).
34. Meduri GU, Rocco PR, Annane D, Sinclair SE. Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome. Expert Rev. Respir. Med. 4(2), 201-210 (2010).
35. Rosenberg AL, Dechert RE, Park PK, Bartlett RH. Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort. J. Intensive Care Med. 24(1), 35-46 (2009).
36. Santacruz JF, Diaz Guzman Zavala E, Arroliga AC. Update in ARDS management: recent randomized controlled trials that changed our practice. Cleve. Clin. J. Med. 73(3), 217-219, 223-215, 229 passim (2006).
37. Thompson BT. Corticosteroids for ARDS. Minerva Anestesiol. 76(6), 441-447 (2010).
38. Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354(24), 2564-2575 (2006). (Pubitemid 43882352)
39. Papazian L, Forel JM, Gacouin A et al. Neuromuscular blockers in early acute respiratory distress syndrome. N. Engl. J. Med. 363(12), 1107-1116 (2010).
40. Chan KK, Lee KL, Lam PK, Law KI, Joynt GM, Yan WW. Hong Kongs experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med. J. 16(6), 447-454 (2010).
41. Forrest P, Ratchford J, Burns B et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med. 37(5), 824-830 (2011).
42. Freed DH, Henzler D, White CW et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can. J. Anaesth. 57(3), 240-247 (2010).
43. Nair P, Davies AR, Beca J et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med. 37(4), 648-654 (2011).
44. Turner DA, Rehder KJ, Peterson-Carmichael SL et al. Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A. Respir. Care 56(7), 941-946 (2011).
45. Peek GJ, Mugford M, Tiruvoipati R et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374(9698), 1351-1363 (2009).
46. Power CA, Van Heerden PV, Moxon D, Martindale G, Roberts B. Extracorporeal membrane oxygenation for critically ill patients with influenza A (H1N1) 2009: a case series. Crit. Care Resusc. 13(1), 38-43 (2011).
47. Kumar A, Zarychanski R, Pinto R et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302(17), 1872-1879 (2009).
48. Kissoon N, Bohn D. Use of extracorporeal technology during pandemics: ethical and staffing considerations. Pediatr. Crit. Care Med. 11(6), 757-758 (2010).
49. Lantos JD. Was the UK collaborative ECMO trial ethical? Paediatr. Perinat. Epidemiol. 11(3), 264-268 (1997).
50. Zwischenberger JB, Lynch JE. Will CESAR answer the adult ECMO debate? Lancet 374(9698), 1307-1308 (2009).
51. Turner DA, Williford WL, Peters MA et al. Development of a collaborative program to provide extracorporeal membrane oxygenation for adults with refractory hypoxemia within the framework of a pandemic. Pediatr. Crit. Care Med. 12(4), 426-430 (2010).
52. Moran JL, Chalwin RP, Graham PL. Extracorporeal membrane oxygenation (ECMO) reconsidered. Crit. Care Resusc. 12(2), 131-135 (2010).
53. Sidebotham D. Extracorporeal membrane oxygenation - understanding the evidence: CESAR and beyond. J. Extra Corpor. Technol. 43(1), 23-26 (2011).
54. Turner DA, Cheifetz IM, Rehder KJ et al. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation - a practical approach. Crit. Care Med. DOI: 10.1097/ CCM.0b013e3182282bbe (2011) (Epub ahead of print).
55. Buck ML. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 18(5), 1082-1086 (1998). (Pubitemid 28439994)
56. Cohen P, Collart L, Prober CG, Fischer AF, Blaschke TF. Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation. Pediatr. Infect. Dis. J. 9(8), 562-566 (1990). (Pubitemid 20260479)
57. Dagan O, Klein J, Gruenwald C, Bohn D, Barker G, Koren G. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther. Drug Monit. 15(4), 263-266 (1993 (Pubitemid 23237575)
58. Mulla H, Lawson G, Von Anrep C et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 15(1), 21-26 (2000). (Pubitemid 30064112)
59. Van Der Vorst MM, Wildschut E, Houmes RJ et al. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation. Crit. Care 10(6), R168 (2006).
60. Watt K, Li J, Benjamin DK Jr., Cohen-Wolkowiez M. Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation. J. Cardiovasc. Pharmacol. 58(2), 126-132 (2011).
61. Arlt M, Philipp A, Zimmermann M et al. First experiences with a new miniaturised life support system for mobile percutaneous cardiopulmonary bypass. Resuscitation 77(3), 345-350 (2008).
62. DAncona G, Capitanio G, Chiaramonte G et al. Extracorporeal membrane oxygenator rescue and airborne transportation of patients with influenza a (H1N1) acute respiratory distress syndrome in a mediterranean underserved area. Interact. Cardiovasc. Thorac. Surg. 12(6), 935-937 (2011).
63. Linden V, Palmer K, Reinhard J et al. Inter-hospital transportation of patients with severe acute respiratory failure on extracorporeal membrane oxygenation - national and international experience. Intensive Care Med. 27(10), 1643-1648 (2001). (Pubitemid 33027962)
64. Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh D, Falke K. Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br. J. Anaesth. 78(3), 241-246 (1997). (Pubitemid 27099910)
65. Muller T, Philipp A, Luchner A et al. A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure. Crit. Care 13(6), R205 (2009).
66. Philipp A, Arlt M, Amann M et al. First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport. Interact. Cardiovasc. Thorac. Surg. 12, 978-981 (2011).
67. Garcia JP, Iacono A, Kon ZN, Griffith BP. Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation. J. Thorac. Cardiovasc. Surg. 139(6), e137-e139 (2010).
68. Mangi AA, Mason DP, Yun JJ, Murthy SC, Pettersson GB. Bridge to lung transplantation using short-term ambulatory extracorporeal membrane oxygenation. J. Thorac. Cardiovasc. Surg. 140(3), 713-715 (2010).
69. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J. Thorac. Cardiovasc. Surg. 139(3), 765-773 e1 (2010).
70. Russo MJ, Davies RR, Hong KN et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J. Thorac. Cardiovasc. Surg. 138(5), 1234-1238 e1 (2009).
71. Gandhi NN, Hartman ME, Williford WL, Peters MA, Cheifetz IM, Turner DA. Successful use of extracorporeal membrane oxygenation for pH1N1-induced refractory hypoxemia in a child with hypoplastic left heart syndrome. Pediatr. Crit. Care Med. (2011) (Epub ahead of print).
72. Hornik CP, Hartman ME, Markert ML, Lodge AJ, Cheifetz IM, Turner DA. Successful extracorporeal membrane oxygenation for respiratory failure in an infant with digeorge anomaly, following thymus transplantation. Respir. Care 56(6), 866-870 (2011).
73. Issa N, Napolitano LM. Aeromonas pneumonia in a trauma patient requiring extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: case report and literature review. Surg. Infect. (Larchmt) 12(3), 241-245 (2011).
74. Leahey AM, Bunin NJ, Schears GJ, Smith CA, Flake AW, Sullivan KE. Successful use of extracorporeal membrane oxygenation (ECMO) during BMT for SCID. Bone Marrow Transplant. 21(8), 839-840 (1998 (Pubitemid 28190632)
75. Extracorporeal Life Support Organization. Patient Specific Guidelines. A supplement to the ELSO General Guidelines (April 2009) www.elso.med.umich.edu/ guidelines.html